Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
NEWARK, DE--(Marketwired - Mar 4, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, has been invited to present at the...
-
NEWARK, DE--(Marketwired - Feb 10, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, reported the initiation of a...
-
NEWARK, DE--(Marketwired - Jan 30, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biopharmaceutical products, has added a...
-
NEWARK, DE--(Marketwired - Jan 21, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, has received a notice...
-
NEWARK, DE--(Marketwired - Jan 15, 2014) - iBio, Inc. (NYSE MKT: IBIO) announced today that the company and Caliber Biotherapeutics have designated a proprietary fusion protein for cancer...
-
NEWARK, DE--(Marketwired - Nov 5, 2013) - iBio, Inc. (NYSE MKT: IBIO), has appointed Carlos Picosse as chief executive officer and Dr. Renato Lobo as chief medical officer of iBio Brazil, a...
-
SAN FRANCISCO, CA--(Marketwired - Sep 5, 2013) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of technology for both proprietary and biosimilar products for use in development and production of...